JENNIFER COTHERN: Open Payments
NPI 1326680638 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 47 payments from 8 companies in 2025. Trend: 2023 $264 · 2024 $598 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $171 |
| Gilead Sciences, Inc. | 7 | $147 |
| Indivior Inc. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 3 | $97 |
| Alkermes, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Braeburn Inc. | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, MAVYRET, REXULTI, VRAYLAR, Auvelity, LYBALVI, VIVITROL.
Industry payments across KY — which companies pay providers there.
